ReviewInternational journal of clinical oncology2026
Mirvetuximab soravtansine in platinum-resistant ovarian cancer: from biological rationale to clinical impact and future directions.
Seiji Mabuchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.